• Policy
• Pfizer’s Bosulif in pricing negotiations for reimb in KOR
• by Lee, Tak-Sun Sep 26, 2023 05:49am

• Policy
• Hanmi is the first to release Zytiga generic at half price
• by Lee, Tak-Sun Sep 25, 2023 05:35am

• Company
• Roche’s Rozlytrek lands in tertiary hospitals in Korea
• by Eo, Yun-Ho Sep 25, 2023 05:34am

• Policy
• Mifegyne, inadequate national essential drug system
• by Lee, Jeong-Hwan Sep 25, 2023 05:34am

• Policy
• Vabysmo·Evrysdi will be reimbursed in October
• by Lee, Jeong-Hwan Sep 25, 2023 05:34am

• Company
• RET-targeted anticancer drugs fail reimb…no promise
• by Eo, Yun-Ho Sep 25, 2023 05:34am

• Company
• Boryung develops 4-drug kanarb combo… increases lineup
• by Chon, Seung-Hyun Sep 22, 2023 05:42am

• Policy
• How Samsung’s biosimilar became covered in the US
• by Lee, Hye-Kyung Sep 22, 2023 05:41am

• Product
• Will Insulin being sold out persist for a long time?
• by Kim JiEun Sep 22, 2023 05:41am

• Company
• Next-gen asthma drug Tezspire to soon be introduced to KOR
• by Eo, Yun-Ho Sep 22, 2023 05:41am